Literature DB >> 29757719

Providing MR Imaging for Cervical Cancer Brachytherapy: Lessons for Radiologists.

Thomas Sullivan1, Joseph H Yacoub1, Matthew M Harkenrider1, William Small1, Murat Surucu1, Steven M Shea1.   

Abstract

Brachytherapy (BT), the use of a locally placed or implanted radioactive source for treatment of an adjacent tumor, is an important component in the treatment of patients with both early- and advanced-stage cervical cancer and is increasingly part of the standard treatment protocol. When it is feasible, many radiation oncologists choose to include a magnetic resonance (MR) imaging examination for planning BT treatment (ie, an MR imaging examination after placement of the applicator but before radiation dosing). MR imaging provides excellent soft-tissue contrast and allows radiation oncologists to individualize the radiation dose to the target volume and minimize the dose to adjacent organs that are at risk for radiation damage. However, traditionally, the radiology department has not performed imaging studies for planning, and the requirements are different compared with those of standard diagnostic imaging. In addition, many applicators are available for use in BT treatment of cervical cancer, and each must considered separately to determine MR safety and to define the best imaging parameters. Starting and supporting a robust gynecologic BT program includes implementing imaging protocols that are helpful to both radiation oncologists and diagnostic radiologists. By becoming more familiar with this treatment modality and the logistics of imaging patients undergoing BT, radiologists can provide imaging support for colleagues in the radiation oncology department and better care for patients. ©RSNA, 2018.

Entities:  

Mesh:

Year:  2018        PMID: 29757719     DOI: 10.1148/rg.2018170033

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  3 in total

1.  Comparison of initial computed tomography-based target delineation and subsequent magnetic resonance imaging-based target delineation for cervical cancer brachytherapy.

Authors:  Taylor J Corriher; Sunil W Dutta; Clayton E Alonso; Bruce Libby; Kara D Romano; Timothy N Showalter
Journal:  J Contemp Brachytherapy       Date:  2020-06-30

2.  Magnetic resonance imaging in cervical cancer interventional radiotherapy (brachytherapy): a pictorial essay focused on radiologist management.

Authors:  Luca Tagliaferri; Benedetta Gui; Luca Russo; Valentina Lancellotta; Maura Miccò; Bruno Fionda; Giacomo Avesani; Angeles Rovirosa; Piotr Wojcieszek; Giovanni Scambia; Riccardo Manfredi
Journal:  J Contemp Brachytherapy       Date:  2022-06-30

3.  Comparative analysis of the value of amide proton transfer-weighted imaging and diffusion kurtosis imaging in evaluating the histological grade of cervical squamous carcinoma.

Authors:  Mengyan Hou; Kai Song; Jipeng Ren; Kaiyu Wang; Jinxia Guo; Yongchao Niu; Zhenyu Li; Dongming Han
Journal:  BMC Cancer       Date:  2022-01-20       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.